Riskpilot← Back to searchSign inGet full accessRØYKEN LEGEKONTOR AS
ASActiveOrg 921404859Bråsetveien 10, 3440 RøykenGeneral medical practice activities · NACE 8621Est. 20184 employees
Revenue 2025
NOK 2,7M
-4% vs 2024
EBITDA margin
2.7%
+222% vs 2024
Equity ratio
-43.3%
Financial strength
Net profit 2025
NOK -20K
+76% vs 2024
| Revenue | NOK 2,7M | -4% |
| EBITDA | NOK 73K | +222% |
| Net profit | NOK -20K | +76% |
| Total assets | NOK 352K | +24% |
| Equity | NOK -152K | -15% |
| Employees | 4 | — |
Legal name
RØYKEN LEGEKONTOR AS
Org number
921404859
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
15. september 2018
Share capital
NOK 30 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller to styremedlemmer i fellesskap
Company purpose
Drifte legekontoret for legene tilknyttet kontoret, investering i verdipapirer og fast eiendom, konsulentvirksomhet samt deltagelse i annen virksomhet.
Address
Bråsetveien 10, 3440 Røyken
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 360 | 2 360 | 2 653 | 2 848 | 2 740 |
| Staff expenses | −968 | −1 026 | −1 178 | −1 183 | −1 199 |
| EBITDA | 43 | −114 | 53 | −60 | 73 |
| Depreciation & amort. | −35 | −34 | −24 | −21 | −73 |
| EBIT | 8 | −148 | 29 | −81 | 0 |
| Net financials | 0 | −0 | 0 | 0 | −0 |
| Profit before tax | 8 | −148 | 29 | −81 | 0 |
| Tax | 2 | −7 | −0 | −0 | 20 |
| Net profit | 6 | −141 | 29 | −81 | −20 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 288 | 221 | 226 | 284 | 352 |
| Equity | 61 | −80 | −51 | −132 | −152 |
| Long-term debt | 7 | 0 | 0 | 0 | 4 |
| Short-term debt | 220 | 301 | 278 | 416 | 501 |
| Total debt | 227 | 301 | 278 | 416 | 505 |
EBITDA margin
2.7%
This company
15.8%
Market median
-83% vs market
20212025
Equity ratio
-43.3%
This company
38.2%
Market median
-213% vs market
20212025
Return on equity
-1988100.0%
This company
18.4%
Market median
-10804991% vs market
20212025
Net profit margin
-0.7%
This company
8.1%
Market median
-109% vs market
20212025
Asset turnover
7.78×
This company
1.12×
Market median
+595% vs market
20212025
Debt / equity
3.31×
This company
0.62×
Market median
-434% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2019 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33% | 33.33% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Peco As
RØYKEN LEGEKONTOR AS Board members of RØYKEN LEGEKONTOR AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christian Steenfeldt-Foss | Chairman | 0 companies |
| Øyvind Helgeland | Board of Directors | 0 companies |
| Espen Grimstad | Board of Directors | 0 companies |
| Geir Helgeland | Board of Directors | 0 companies |